Evidence map›Paper›PMID 34548040›Full record

ArticleBMC public health2021

Diagnosis patterns of sickle cell disease in Ghana: a secondary analysis.

Alexandra M Sims, Kwaku Osei Bonsu, Rebekah Urbonya, Fatimah Farooq, Fitz Tavernier, Marianna Yamamoto, Sheri VanOmen, Brittne Halford, Polina Gorodinsky, Rachel Issaka and 13 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 2 countries.

Alexandra M SimsChildren's National Hospital, Washington, DC, USA. Alexandra.sims@cchmc.org.
Kwaku Osei BonsuUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Rebekah UrbonyaUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Fatimah FarooqUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Fitz TavernierUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Marianna YamamotoUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Sheri VanOmenUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Brittne HalfordUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Polina GorodinskyUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Rachel IssakaUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Tulana KpadenouUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Rhonda DouglasUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Samuel WilsonUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Clementine FuUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Danielle CanterUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Duña MartinUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Austin NovarraUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Lewis GrahamUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Fredericka SeyGhana Institute of Clinical Genetics, Korle Bu Teaching Hospital, Accra, Ghana.
Charles Antwi-BoasiakoDepartment of Physiology, University of Ghana Medical School, Accra, Ghana.
Catherine SegbefiaDepartment of Child Health, University of Ghana Medical School, Accra, Ghana.
Onike RodriguesDepartment of Child Health, Korle Bu Teaching Hospital, Accra, Ghana.
Andrew CampbellChildren's National Hospital, Washington, DC, USA.
University of Michigan–Ann Arbor · USKorle Bu Teaching Hospital · GHChildren's National · USUniversity of Ghana · GH

Funding

University of Michigan Minority Health and Health Disparities International Research Training ProgramT37MD001425 · NIMHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOULTON, MATTHEW LESTER · 2005 to 2025
$4.8M
Novel Cilia Trafficking MechanismsR01DK084725 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARGOLIS, BENJAMIN L · 2009 to 2010
$702k
NIDDK NIH HHS R01 DK084725NIMHD NIH HHS T37 MD001425
6 · The paper itself

Abstract

backgroundDespite having the highest prevalence of sickle cell disease (SCD) in the world, no country in Sub-Saharan Africa has a universal screening program for the disease. We sought to capture the diagnosis patterns of SCD (age at SCD diagnosis, method of SCD diagnosis, and age of first pain crisis) in Accra, Ghana.

methodsWe administered an in-person, voluntary survey to parents of offspring with SCD between 2009 and 2013 in Accra as a part of a larger study and conducted a secondary data analysis to determine diagnosis patterns. This was conducted at a single site: a large academic medical center in the region. Univariate analyses were performed on diagnosis patterns; bivariate analyses were conducted to determine whether patterns differed by participant's age (children: those < 18 years old whose parents completed a survey about them, compared to adults: those > = 18 years old whose parents completed a survey about them), or their disease severity based on SCD genotype. Pearson's chi-squared were calculated.

resultsData was collected on 354 unique participants from parents. Few were diagnosed via SCD testing in the newborn period. Only 44% were diagnosed with SCD by age four; 46% had experienced a pain crisis by the same age. Most (66%) were diagnosed during pain crisis, either in acute (49%) or primary care (17%) settings. Children were diagnosed with SCD at an earlier age (74% by four years old); among the adults, parents reflected that 30% were diagnosed by four years old (p < 0.001). Half with severe forms of SCD were diagnosed by age four, compared to 31% with mild forms of the disease (p = 0.009).

conclusionsThe lack of a robust newborn screening program for SCD in Accra, Ghana, leaves children at risk for disease complications and death. People in our sample were diagnosed with SCD in the acute care setting, and in their toddler or school-age years or thereafter, meaning they are likely being excluded from important preventive care. Understanding current SCD diagnosis patterns in the region can inform efforts to improve the timeliness of SCD diagnosis, and improve the mortality and morbidity caused by the disease in this high prevalence population.

Indexed as

Anemia, Sickle CellAdolescentChild, PreschoolGhanaHumansInfant, NewbornNeonatal ScreeningPainPrevalence

Identifiers

PMID34548040
PMCPMC8456625
OpenAlexW3200180007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.